Regulatory Updates

FDA, EMA, TGA and global regulatory developments

#USWM ×

Regulatory Updates

Aug 30, 2026•1 min read

FDA Approves REVONTO (Dantrolene Sodium) Injectable – ANDA078378

The FDA has approved the ANDA for REVONTO, a 20 mg/vial injectable dantrolene sodium product from USWM, LLC, for prescription use.